The JSE was firmer on Thursday, with its global peers mixed as investors pin their hope on Covid-19 vaccine rollouts, while investor focus also remains on the US stimulus deal.

Now that Britain has beaten the rest of the world in approving a German-US Covid vaccine candidate, the US looks to be next in line, with the US Food and Drug Administration (FDA) decision on the shot expected in mid-December. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now